Neuroethical Issues In Cognitive Enhancement Research Paper

Cognitive Therapy Importance of Cognitive-enhancing drugs

Methods of boosting an individual's brain power

Research for cognitive enhancers

The interest in Cognitive enhancement

The neuroethics associated with cognitive enhancements

Observations

The article titled "Neuroethical issues in cognitive enhancement" was written by the authors Barbara Sahakian and Sharon Morein-Zamir and was first published online on March 8, 2010. Neuroethics is a field that addresses the applied ethical issues that are brought directly or indirectly about by neuroscience advancements. One area is on the research and development of enhancers in pharmaceutical cognition. These drugs are mainly developed for the treatment of cognitive disabilities and improving the quality of life of patients with brain injuries and neuropsychiatric disorders. This report endeavors to review the impact that such drugs have in both healthy and neuropsychiatric individuals and the overall implications on the society as a new development in the field of psychology (Sahakian & Morein-Zamir, 2011).

Importance of Cognitive-enhancing drugs

These drugs are also considered as smart drugs and are used in the treatment of cognitive disabilities. They are also essential in enhancing the value of life for those individuals...

...

They also treat disorders like Attention Deficit Hyperactivity, Schizophrenia, and Alzheimer's disease. These drugs slow down as well as compensate for the decline in behavioral and cognitive function. The cognitive enhancers are beneficial to both neuropsychiatric disorders and neurodegenerative disorders. For instance, it is commonly known that delusions and hallucinations are cognitive impairments that often impede the value of life of patients and impede their everyday function.
Methods of boosting an individual's brain power

The pharmaco-cognitive enhancers are primarily used for this function. Other methods include transcranial magnetic stimulation, neuroprosthetics for cognition, physical exercise, education and cognitive training and cognitive activation.

Research for cognitive enhancers

Various methods are used in testing the effects caused by cognitive enhancers on perception. One of the methods is the use of double-blind placebo-controlled studies that require an individual to measure several facets of cognition like attention, executive functions, and memory. According to research, methylphenidate is seen to improve spatial working memory performance in young and adult patients suffering from ADHD (Cakic, 2009).

Psychopharmacological…

Sources Used in Documents:

References

Sahakian, B.J. & Morein-Zamir, S. (2011). Neuroethical issues in cognitive enhancement. Journal of Psychopharmacology. 25(2) 197 -- 204 originally published online 8 March 2010 DOI: 10.1177/0269881109106926

Cakic, V. (2009). Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology. J Med Ethics, 35:611-615 doi:10.1136/jme.2009.030882


Cite this Document:

"Neuroethical Issues In Cognitive Enhancement" (2014, April 16) Retrieved April 19, 2024, from
https://www.paperdue.com/essay/neuroethical-issues-in-cognitive-enhancement-188173

"Neuroethical Issues In Cognitive Enhancement" 16 April 2014. Web.19 April. 2024. <
https://www.paperdue.com/essay/neuroethical-issues-in-cognitive-enhancement-188173>

"Neuroethical Issues In Cognitive Enhancement", 16 April 2014, Accessed.19 April. 2024,
https://www.paperdue.com/essay/neuroethical-issues-in-cognitive-enhancement-188173

Related Documents

Psychopharmacology It was only in the 1950s when psychiatric drugs to treat severe depression were first developed. Prior to that, most people had to suffer with their emotional pain and its attached sigma. Many individuals had to be admitted to mental hospitals. Now, psychiatrists can prescribe any of hundreds of medications for this illness and, in the majority of cases, have successful results. Monoamine Oxidase Inhibitors or MAOs were the first pharmaceuticals

psychopharmacology, the goal is to use drugs to improve brain function. This takes place via very specific actions within the brain. The drug may be administered in one of several ways, and its metabolism will vary based on many factors, making psychopharmacology a complicated medical issue. In addition, some people abuse substances known to have a psychopharmalogical effect. Both the appropriate and inappropriate use of these drugs can have

Psychopharmacology Treatment for Alzheimers Disease The purpose of this paper is to evaluate the three treatment options for Mr. Akkad suffering from Alzheimer's disease. Mr. Akkad is a 76-year Iranian patient demonstrating some strange behaviors. The patient has started losing interest in the major religious activities, which is critical for a member of the family. Moreover, he has started abandoning things he uses to take very seriously before, and these things

Psychopharmacology Website: www.bap.org.uk The British Association of Psychopharmacology (BAP)(n.d.) is a scholarly society and enlisted philanthropy. It advances exploration and instruction in psychopharmacology and related zones, and unites individuals in the educated community, well-being administrations, and industry. Shaped in 1974, it is the biggest such national relationship in Europe, and the second biggest in the world. The website has a lot of different content available that would help me in my coursework.

Psychopharmacology Non-medical psychotherapists, such as Marriage and Family Therapists, should learn about psychopharmacology in order to: Collaborate with prescribers regarding a patient's medication For a patient with a borderline or dependent personality, a therapist not recommending medication would likely be seen as: Conservative Jim is disturbed by his psychiatrist's prescription of psychotropic medication, believing that the psychiatrist is attempting to control him and remove his autonomy. This most likely reflects: Paranoid personality traits Short, branched structures projecting

Psychopharmacology Case Study Possible etiologies Generalized anxiety disorder (GAD). GAD or as it is known in full generalized anxiety disorder is a widespread anxiety complication that is characterized by worrying chronically, tension and nervousness. This is different from a phobia; which is characterized by fear of something specific or situation. GAD diffuses a feeling of dread and unease spanning all aspects of one's life. The anxiety is not as intensive as a panic